Search Ontology:
ChEBI

LY-411575

Term ID
CHEBI:87359
Synonyms
  • LSN-411575
  • LY-411575
  • LY411575
  • N(2)-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-N-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide
  • N(2)-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N(1)-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide
Definition
A dibenzoazepine that is 5,7-dihydro-6H-dibenzo[b,d]azepin-6-one which is substituted at the 7 pro-S position by the C-terminal carboxamide nitrogen of N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-L-alaninamide. It is a potent, cell permeable and selective γ-secretase inhibitor. It has been tested as a possible treatment for Alzheimer's disease and shows promise for its potential to counteract severe hearing loss.
References
  • pubmed:14718585
  • pubmed:15743924
  • pubmed:17897827
  • pubmed:19419556
  • pubmed:22824752
  • pubmed:23209290
  • pubmed:23312516
  • pubmed:23901284
  • pubmed:24113577
  • pubmed:24223998
  • pubmed:24884926
  • pubmed:25781991
  • reaxys:10736555
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from LY-411575
Phenotype where environments contain LY-411575
Phenotype modified by environments containing LY-411575
Phenotype affecting LY-411575
Human Disease Model